William E Evans
William E Evans
Verified email at stjude.org
TitleCited byYear
Pharmacogenomics: translating functional genomics into rational therapeutics
WE Evans, MV Relling
science 286 (5439), 487-491, 1999
28451999
Acute lymphoblastic leukemia
CH Pui
Encyclopedia of Cancer, 23-26, 2011
25392011
Treatment of acute lymphoblastic leukemia
CH Pui, WE Evans
New England Journal of Medicine 354 (2), 166-178, 2006
20782006
Treatment of acute lymphoblastic leukemia
CH Pui, WE Evans
New England Journal of Medicine 354 (2), 166-178, 2006
20782006
Pharmacogenomics—drug disposition, drug targets, and side effects
WE Evans, HL McLeod
New England journal of medicine 348 (6), 538-549, 2003
20592003
Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling
EJ Yeoh, ME Ross, SA Shurtleff, WK Williams, D Patel, R Mahfouz, ...
Cancer cell 1 (2), 133-143, 2002
20562002
Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia
CG Mullighan, S Goorha, I Radtke, CB Miller, E Coustan-Smith, JD Dalton, ...
Nature 446 (7137), 758, 2007
16172007
The genetic basis of early T-cell precursor acute lymphoblastic leukaemia
J Zhang, L Ding, L Holmfeldt, G Wu, SL Heatley, D Payne-Turner, ...
Nature 481 (7380), 157, 2012
11462012
Treating childhood acute lymphoblastic leukemia without cranial irradiation
CH Pui, D Campana, D Pei, WP Bowman, JT Sandlund, SC Kaste, ...
New England Journal of Medicine 360 (26), 2730-2741, 2009
9272009
Molecular diagnosis of thiopurine S-methyltransferase deficiency: genetic basis for azathioprine and mercaptopurine intolerance
CR Yates, EY Krynetski, T Loennechen, MY Fessing, HL Tai, CH Pui, ...
Annals of internal medicine 126 (8), 608-614, 1997
8501997
Moving towards individualized medicine with pharmacogenomics
WE Evans, MV Relling
Nature 429 (6990), 464, 2004
8042004
Acute myeloid leukemia in children treated with epipodophyllotoxins for acute lymphoblastic leukemia
CH Pui, RC Ribeiro, ML Hancock, GK Rivera, WE Evans, SC Raimondi, ...
New England Journal of Medicine 325 (24), 1682-1687, 1991
7471991
Mercaptopurine Therapy Intolerance and Heterozygosity at the Thiopurine S-Methyltransferase Gene Locus
MV Relling, ML Hancock, GK Rivera, JT Sandlund, RC Ribeiro, ...
Journal of the National Cancer Institute 91 (23), 2001-2008, 1999
7231999
Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia
KG Roberts, Y Li, D Payne-Turner, RC Harvey, YL Yang, D Pei, ...
New England journal of medicine 371 (11), 1005-1015, 2014
6982014
A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study
ML Den Boer, M van Slegtenhorst, RX De Menezes, MH Cheok, ...
The lancet oncology 10 (2), 125-134, 2009
6732009
Pharmacogenomics and individualized drug therapy
M Eichelbaum, M Ingelman-Sundberg, WE Evans
Annu. Rev. Med. 57, 119-137, 2006
6652006
Clinical pharmacogenetics implementation consortium guidelines for thiopurine methyltransferase genotype and thiopurine dosing: 2013 update.
R MV, G EE, S WJ, S K, P CH, Y SW, S CM, C M, E WE, H JK, S M, K TE, ...
Clinical Pharmacology & Therapeutics 93 (4), 324-325, 2013
623*2013
Clinical Pharmacogenetics Implementation Consortium guidelines for thiopurine methyltransferase genotype and thiopurine dosing.
R MV, G EE, S WJ, S K, P CH, Y SW, S CM, C M, E WE, K TE, ...
Clinical Pharmacology & Therapeutics 89 (3), 387-391, 2011
6232011
Gene-expression patterns in drug-resistant acute lymphoblastic leukemia cells and response to treatment
A Holleman, MH Cheok, ML den Boer, W Yang, AJP Veerman, ...
New England Journal of Medicine 351 (6), 533-542, 2004
6002004
Genetic alterations activating kinase and cytokine receptor signaling in high-risk acute lymphoblastic leukemia
KG Roberts, RD Morin, J Zhang, M Hirst, Y Zhao, X Su, SC Chen, ...
Cancer cell 22 (2), 153-166, 2012
5402012
The system can't perform the operation now. Try again later.
Articles 1–20